A quantitative evaluation of total antioxidant status and oxidative stress markers in preeclampsia and gestational diabetic patients in 24-36 weeks of gestation.
about
Endothelial dysfunction and preeclampsia: role of oxidative stressCatalase prevents maternal diabetes-induced perinatal programming via the Nrf2-HO-1 defense systemAntioxidant Status and Risk of Gestational Diabetes Mellitus: a Case-Control StudyAlterations in antioxidant system, mitochondrial biogenesis and autophagy in preeclamptic myometrium.Preeclampsia and diabetes.Surrogate markers of the kidney and liver in the assessment of gestational diabetes mellitus and fetal outcome.Effects of the interaction of diabetes and iron supplementation on hepatic and pancreatic tissues, oxidative stress markers, and liver peroxisome proliferator-activated receptor-α expression.Evaluation of advanced oxidation protein products, prooxidant-antioxidant balance, and total antioxidant capacity in untreated vitiligo patients.Hyperglycemia Differentially Affects Maternal and Fetal DNA Integrity and DNA Damage Response.Skeletal muscle MnSOD, mitochondrial complex II, and SIRT3 enzyme activities are decreased in maternal obesity during human pregnancy and gestational diabetes mellitusPlasma Markers of Oxidative Stress in Patients with Gestational Diabetes Mellitus in the Second and Third Trimester.Serum FRAP Levels and Pre-eclampsia among Pregnant Women in a Rural Community of Northern India.Health Effects of Carotenoids during Pregnancy and Lactation.Pathophysiology and Current Clinical Management of Preeclampsia.A specific, accurate, and sensitive measure of total plasma malondialdehyde by HPLC.Myeloperoxidase is not a good biomarker for preeclampsia prediction.Implications of maternal systemic oxidative stress in normal pregnancy and in pregnancy complicated by preeclampsia.Total antioxidant status and markers of oxidative stress in subjects with normal or impaired glucose regulation (IFG, IGT) in diabetic patients.Oxidative stress and antioxidant status in patients with late-onset gestational diabetes mellitus.Influence of gestational diabetes on the activity of δ-aminolevulinate dehydratase and oxidative stress biomarkers.Oxidative and carbonyl stress in pregnant women with obstructive sleep apnea.The postpartum effect of maternal diabetes on the circulating levels of sirtuins and superoxide dismutase.Increased Oxidatively Modified Forms of Albumin in Association with Decreased Total Antioxidant Activity in Different Types of Hypertensive Disorders of Pregnancy.Relationship Between Xanthine Oxidase, Ischemia Modified Albumin, Nitric Oxide with Antioxidants in Non Pregnants, Pre and Post-delivery of Normal Pregnants and Preeclampsia.Role of serum levels of irisin and oxidative stress markers in pregnant women with and without gestational diabetes.Evaluation of serum ischemia-modified albumin levels in pregnant women with and without gestational diabetes mellitus.PHBV/PCL microparticles for controlled release of resveratrol: physicochemical characterization, antioxidant potential, and effect on hemolysis of human erythrocytes.Exercise and its role in gestational diabetes mellitus.
P2860
Q27004643-F744D5B7-CEA8-4F64-B466-3E0E1DFDB0B5Q28578371-80CF215D-3B49-4CEA-8527-63EF5B208C3FQ33661250-34C7A704-2136-43AC-AB96-4932F05B9A99Q33907624-2517E380-B0F3-48DF-AA1A-90EEF4447B03Q35051099-93C28623-7087-45ED-B368-9E3B987AFD13Q35139692-57D0314B-1041-45C2-AD6C-749B1BF774FCQ35209655-74034F2B-E154-4874-BF3F-07ED9DB9B55AQ35226805-74C4ECFD-0C85-44AF-A49F-D8FFDEB7CAD0Q36727120-D5ADCD1E-22EC-44AD-8654-2B49B3614DE0Q37215481-758E8190-D1E3-44D7-91A9-48B214F06F2AQ37359754-E36E1F5E-1567-4926-9370-90B0C962983DQ37435483-A5C11FDA-9502-4CA3-A120-9058C8D9DEFEQ38640978-AB90DA18-5BF0-491A-88BC-333BE2226D65Q39423454-8FB49F6A-5F77-4BC5-80EB-9068D0BF6FA8Q39633244-5B7CD820-BA47-4A8C-AF20-1EDC68B243F6Q41580008-19B634A1-6E61-47C4-AA08-330EF7BAA6CDQ43647467-DB73ED84-8ABF-4F40-894D-20024774532BQ46060210-21EC393F-8387-4AA1-9AF5-4F5D18F3DCCAQ46272669-2BFD79CE-69E7-46B6-A937-A67FBA843320Q47392151-D4A36B8A-52B7-4D7B-BE00-F139DE9C0FB6Q47760172-72F657A1-09B3-4460-A7F8-1C760B74C7EBQ49430045-DCC3CF4B-02A0-4342-A00D-37B1C184D776Q51043406-3651984F-BDF3-444D-BE78-BE172AE20444Q51043412-54BF7D51-1DF9-4646-B3E4-D89ED2ED2FCAQ51104652-4B85F512-9C42-4E98-82F8-8C99102939F4Q51357068-EAE5D926-8A1B-43F3-8109-E6967C8FA7FFQ51358876-64AF45F4-0039-4F16-953D-259004FECBAFQ52905017-498433CF-995F-4656-9D18-74F1317FF9A4
P2860
A quantitative evaluation of total antioxidant status and oxidative stress markers in preeclampsia and gestational diabetic patients in 24-36 weeks of gestation.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
A quantitative evaluation of t ...... s in 24-36 weeks of gestation.
@en
A quantitative evaluation of t ...... s in 24-36 weeks of gestation.
@nl
type
label
A quantitative evaluation of t ...... s in 24-36 weeks of gestation.
@en
A quantitative evaluation of t ...... s in 24-36 weeks of gestation.
@nl
prefLabel
A quantitative evaluation of t ...... s in 24-36 weeks of gestation.
@en
A quantitative evaluation of t ...... s in 24-36 weeks of gestation.
@nl
P2093
P1476
A quantitative evaluation of t ...... s in 24-36 weeks of gestation.
@en
P2093
Aylin Sepici-Dincel
Deniz Karcaaltincaba
Duygu Sahin
Mesut Akyol
Nilgün Altan
Omer Kandemir
Ozlem Karacay
Serdar Yalvaç
P304
P356
10.1016/J.DIABRES.2010.04.015
P577
2010-09-01T00:00:00Z